VNDA
Vanda Pharmaceuticals Inc
4.50$
-0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.2% | 13.8% | 10.7% | 10.8% | 10.9% | 10.8% | 10.5% | 11.0% | 10.3% | 10.7% | 10.7% | 10.8% | 11.4% | 10.2% | 9.0% | 9.4% | 9.8% | 9.5% | 9.6% | 9.7% | 9.7% | 9.2% | 9.4% | 9.4% | 9.7% | 9.7% | 7.6% | 7.6% | 7.9% | 7.6% | 11.5% | 8.9% | 5.4% | 4.9% | 7.0% | 8.5% | 5.3% | 6.7% | 10.0% | 7.0% | 7.2% | |
| 81.8% | 86.2% | 89.3% | 89.2% | 89.1% | 89.2% | 89.5% | 89.0% | 89.7% | 89.3% | 89.3% | 89.2% | 88.6% | 89.8% | 91.0% | 90.6% | 90.2% | 90.5% | 90.4% | 90.3% | 90.3% | 90.8% | 90.6% | 90.6% | 90.3% | 90.3% | 92.4% | 92.4% | 92.1% | 92.4% | 88.5% | 91.1% | 94.6% | 95.1% | 93.0% | 91.5% | 94.7% | 93.3% | 90.0% | 93.0% | 92.8% | |
| 19.0% | 19.9% | 28.2% | 18.2% | 24.6% | 22.9% | 21.6% | 20.8% | 23.2% | 24.4% | 27.8% | 18.5% | 19.1% | 21.5% | 26.8% | 20.7% | 20.4% | 21.9% | 25.7% | 29.8% | 28.0% | 28.4% | 34.8% | 33.4% | 38.1% | 28.6% | 30.8% | 36.1% | 42.8% | 53.8% | 44.6% | 33.0% | 35.2% | 37.3% | 71.4% | 41.8% | 40.1% | 50.7% | 55.0% | 73.1% | 54.2% | |
| 56.9% | 58.9% | 81.0% | 74.6% | 75.3% | 67.2% | 61.5% | 59.0% | 53.0% | 45.3% | 65.0% | 53.3% | 50.8% | 55.5% | 63.8% | 54.5% | 56.4% | 34.0% | 47.5% | 41.7% | 46.3% | 39.3% | 67.9% | 51.3% | 45.7% | 46.8% | 57.8% | 61.7% | 63.8% | 51.1% | 63.4% | 78.2% | 78.9% | 70.3% | 100.1% | 122.9% | 107.1% | 110.1% | 132.2% | 142.2% | 122.1% | |
| 83.5% | 87.9% | 110.4% | 93.8% | 101.0% | 94.0% | 83.9% | 80.7% | 77.0% | 72.1% | 93.7% | 72.5% | 70.5% | 82.8% | 91.2% | 75.9% | 77.4% | 75.1% | 73.9% | 72.1% | 74.9% | 78.1% | 103.3% | 85.2% | 84.3% | 80.0% | 89.2% | 98.6% | 107.6% | 108.0% | 108.0% | 111.2% | 117.7% | 114.5% | 182.0% | 164.7% | 150.4% | 163.8% | 187.2% | 219.2% | 178.9% | |
| -1.7% | -1.7% | -21.1% | -4.6% | -11.9% | -4.9% | 5.6% | 8.3% | 12.7% | 17.3% | -4.4% | 16.8% | 18.1% | 7.0% | -0.2% | 14.7% | 12.8% | 15.4% | 16.5% | 18.2% | 15.4% | 12.7% | -12.7% | 5.4% | 6.0% | 10.3% | 3.2% | -6.2% | -15.4% | -15.7% | -19.5% | -20.1% | -23.1% | -19.3% | -89.0% | -73.2% | -55.6% | -70.5% | -97.1% | -126.3% | -86.1% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | 0.2% | 0.5% | 2.4% | 4.6% | 5.6% | – | – | 7.8% | – | – | – | – | – | – | – | – | – | – | – | |
| -1.1% | -1.3% | -20.4% | -3.6% | -11.0% | -4.0% | 7.0% | 9.9% | 14.8% | 19.5% | -1.3% | 19.5% | 20.6% | 9.5% | 2.1% | 17.8% | 13.9% | 16.1% | 16.6% | 18.6% | 15.3% | 12.7% | -12.6% | 5.9% | 8.4% | 14.9% | 8.8% | 5.6% | -0.3% | -3.7% | -9.8% | -10.9% | -13.1% | -12.2% | -74.7% | -66.3% | -50.5% | -66.4% | -93.6% | -123.5% | -82.1% | |
| 0.0% | 0.3% | 0.1% | 0.0% | 0.1% | 0.2% | 0.0% | 0.2% | 0.2% | -0.1% | 0.0% | 0.0% | -148.2% | 2.6% | 1.3% | 3.8% | 4.1% | 4.0% | 2.8% | 4.3% | 4.2% | 2.3% | -1.9% | 1.9% | 3.4% | 4.3% | 3.6% | 2.3% | -0.7% | 1.6% | -1.1% | -2.0% | -1.9% | -3.0% | -15.7% | -14.6% | -10.3% | 180.3% | 0.3% | 0.3% | 45.3% | |
| -1.1% | -1.6% | -20.4% | -3.6% | -11.0% | -4.2% | 7.0% | 9.7% | 14.6% | 19.5% | -1.3% | 19.5% | 168.8% | 6.9% | 0.8% | 14.0% | 9.9% | 12.1% | 13.8% | 14.2% | 11.1% | 10.4% | -10.7% | 4.0% | 5.0% | 10.6% | 5.2% | 3.3% | 0.4% | -5.3% | -8.7% | -9.0% | -11.2% | -9.2% | -58.9% | -51.7% | -40.1% | -246.8% | -93.9% | -123.7% | -127.4% | |
| 6.5% | 4.5% | -19.2% | -2.8% | -10.0% | -3.1% | 7.2% | 9.9% | 14.2% | 18.7% | -3.6% | 20.8% | 21.9% | 8.2% | 1.0% | 15.9% | 14.0% | 17.2% | 17.6% | 19.6% | 16.3% | 13.7% | -11.4% | 7.0% | 9.4% | 15.9% | 9.9% | 6.9% | 1.2% | -1.1% | -5.1% | -7.0% | -9.0% | -8.5% | -62.2% | -62.5% | -46.8% | -56.2% | -86.8% | -125.2% | -77.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.